Early Detection Research Network

Filter By Principal Investigator

• Anna Lokshin 
• Wan Lam 
• Daniel Liebler 
• Peter Barker 
• Canary 
• Muneesh Tewari 
• Jeffrey Marks 
• Adi Gazdar 
• Alvin Liu 
• John Semmes 
• Ite A. Laird-Offringa 
• Samir Hanash 
•  
• Daniel Cramer 
• Bill Grizzle 
• Eleftherios Diamandis 
• Brian Haab 
• Stephen J. Meltzer, MD 
• Timothy W. Randolph 
• Chris Kinsinger 
• Unknown 

Filter By Protocol

• SPORE/EDRN/PLCO Ovarian Validation Study 
• Identification of biomarkers for lung cancer in never smokers 
•  
• Validation of the Mutagen Sensitivity and Chromosomal Hotspot Assays 
• Expression based markers for breast cancer detection 
• Prostate & Bladder Cancer Biomarkers 
• SELDI Phase I: Assay Validation-Prostate 
• EDRN-WHI Pre-Clinical Colon Ca Specimens 
• SELDI Validation Study Phase II 
• Validation of Protein Markers for Lung Cancer Using CARET Sera and Proteomics Techniques 
• PLCO Ovarian Validation Study 
•  
• Pancreatic Cancer Early Detection Stem Cell Biomarkers 
• Prostate Rapid Reference Set Applicant: Diamandis - Mt Sinai (2006) 
• Prostate Rapid Reference Set Application: Haab - Van Andel (2006) 
• Barrett's Esophogus Methylation Profiles 
• MALDI Dilution Data: Randolph 
• Clinical Proteomic Technologies for Cancer Initiative (CPTAC) Phase 1 
•  
• Clinical Utility of Urinary CD90 as a Biomarker for Prostate Cancer Detection 

Filter By Collaborative Group

Filter By Participating Site

• Fred Hutchinson Cancer Research Center (Data Management and Coordinating Center) 
•  
• Vanderbilt University School of Medicine 
• National Institute of Standards and Technology (Associate Member) 
• Canary Foundation 
•  
• Duke University Medical Center (Biomarker Developmental Laboratories) 
• UT Southwestern Medical Center (Biomarker Developmental Laboratories) 
• University of Washington (Biomarker Developmental Laboratories) 
• Eastern Virginia Medical School (Biomarker Developmental Laboratories) 
•  
• Wistar (Associate Member) 
• Johns Hopkins University (Biomarker Developmental Laboratories) 
• Fred Hutchinson Cancer Research Center (Biomarker Developmental Laboratories) 
• University of Washington (Associate Member) 
• Johns Hopkins Medical Institutions (Biomarker Reference Laboratories) 
• Karmanos Cancer Institute (Biomarker Developmental Laboratories) 
• Johns Hopkins University (Associate Member) 
• Harvard University (Non-EDRN Site) 
• Pacific Northwest National Laboratory (Associate Member) 
• University of Michigan (Biomarker Developmental Laboratories) 
• Brigham and Women's Hospital (Clinical Epidemiology and Validation Center) 
• North Eastern University 
• University of Alabama at Birmingham (Biomarker Reference Laboratories) 
• University of Pittsburgh Cancer Instititute (Biomarker Developmental Laboratories) 
• Mount Sinai Hospital (Associate Member) 
• Van Andel Research Institute (Associate Member) 
• Johns Hopkins University (Biomarker Developmental Laboratories) 
• University of Pittsburgh Cancer Institute (Biomarker Developmental Laboratories) 
• National Cancer Institute (NCI) 
•